Monthly Medical Update – Issue 5

Director of Life & Health - Medical Intelligence

Nicola is considered a leading expert in Public Health and associated Mortality, Morbidity & Longevity risk.

Areas of specialist knowledge include; public health policy, socioeconomic disparities, impact of risk behaviours on life expectancy & future infectious disease risks.

Nicola supports actuaries from many of the leading consultancies, pension & insurance companies in Europe and the US, with underwriting, annuity pricing, product development as well as internal model calibration to fulfil regulatory requirement.

She leads a small research team within Medical Intelligence and continues to regularly present her work and speak at events for and on behalf of clients and to wider public audiences.

Prior to co-founding Medical Intelligence in 2007, Nicola worked for the NHS for 19 years specialising in Public Health, this followed many years in senior roles in Intensive Care Nursing and Paediatrics.

Nicola trained as a nurse and subsequently studied at Homerton College University of Cambridge, graduating with a PgDip in Neonatal Special and Intensive Care followed up with a BSc (Hons) in Public Health (Specialist Community).

Nicola has also studied Epidemiology with the London School of Hygiene & Tropical Medicine and Statistics.

Chief Science Officer - COIOS Research

Dan is an epidemiologist and digital demographer with 25 years experience in the insurance industry.

He led global multi-disciplinary research teams at Swiss Re and Willis Towers Watson in diverse areas including forward-looking risk models, behavioural science and the rapid development of digital ecosystems that will transform how insurance is distributed and how risk is assessed, managed and mitigated.

Dan is an internationally recognised expert on demographic trends, emerging insurance risks and digital innovation. He pioneered the concept of disease-based models of mortality using electronic health records and was a key contributor to the development of the Pandemic Emergency Facility with the Institute of Medicine, WHO and World Bank.

Dan has an MA in Medical Sciences from Cambridge University and an MBA from Heriot-Watt University. He is currently engaged in a DHealth at the University of Bath that is examining the role of medication adherence in improving the management of hypertension in stroke.